BIT 2.22% 4.6¢ biotron limited

Newly designed targeted compounds for COVID-19

  1. 11 Posts.
    lightbulb Created with Sketch. 1
    Report outlines Bitron have developed a new targeted set of compounds to test for antiviral activity against SARS-CoV-2. This is a good step forward from late last year when they said they were testing their library of compounds. They have clearly completed the screening of their compounds and through that process have developed something new and targeted to take forward into testing. That is great news!
    Last edited by lucky2000: 29/01/21
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.001(2.22%)
Mkt cap ! $41.50M
Open High Low Value Volume
4.4¢ 4.7¢ 4.4¢ $31.64K 708.3K

Buyers (Bids)

No. Vol. Price($)
4 259000 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 17361 1
View Market Depth
Last trade - 14.10pm 21/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.